Routine Early Antibiotic Use in SymptOmatic Preterm Neonates: A Pilot Randomized Controlled Trial

Area of Science:

• Neonatal Medicine
• Pediatric Infectious Diseases
• Clinical Trials

Background:

• Preterm infants, especially those born before 33 weeks gestation, are at increased risk for infections.
• The use of antibiotics in this vulnerable population requires careful evaluation due to potential adverse effects.
• Establishing safe and effective treatment protocols for preterm neonates is a critical area of research.

Purpose of the Study:

• To conduct a pilot randomized trial comparing the use of antibiotics versus no antibiotics in preterm infants.
• To assess the safety and feasibility of a larger multicentered trial investigating antibiotic use in neonates.
• To gather preliminary data on adverse events in preterm infants based on antibiotic administration.

Main Methods:

• Pilot randomized controlled trial design.
• Enrolled 98 infants with gestational age less than 33 weeks.
• Randomized 55 infants to either antibiotic or no antibiotic groups, considering maternal infectious risk and expected symptoms.

Main Results:

• Adverse events were monitored in both randomization arms.
• No statistically significant difference in adverse events was observed between the antibiotic and no-antibiotic groups.
• The study successfully established a framework for future research.

Conclusions:

• The pilot trial demonstrated the feasibility of conducting a larger study on antibiotic use in preterm infants.
• Antibiotic administration in this specific cohort of preterm infants did not lead to a significantly higher incidence of adverse events compared to no antibiotics.
• This research provides a foundation for a more extensive multicentered trial to further elucidate the role of antibiotics in preterm neonates.